President Donald Trump’s Day One executive order rescinding Biden-era Medicare and Medicaid price innovation programs signals ...
1don MSN
Senators grilled Robert F. Kennedy Jr. on if and how he would reform Medicaid and Medicare during his first confirmation ...
RFK Jr.'s second Senate confirmation hearing focused on vaccines, Medicare, diversity, and science. Key Republicans were reticent to show support.
Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...
The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process ...
The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started ...
Vertex Pharmaceuticals won approval from the U.S. Food and Drug Administration for a non-opioid pain drug, clearing the way for the rollout of a product that has simultaneously sparked high hopes and ...
Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the different forms as a single product.
The U.S. Food and Drug Administration (FDA) recently issued two new guidance documents governing details of the Accelerated Approval ...
Kennedy seeks to be Secretary of Health and Human Services — a position that would put him in charge of the health of the ...
Ozempic is approved by the U.S. Food and Drug Administration to treat Type 2 ... has proposed a rule to include weight loss drugs under Medicare, though the finalization of that rule will land ...
The final round of committee hearings for Kennedy’s bid to be HHS Secretary was contentious from the start.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback